Compass Pathways: Leading the Psilocybin Revolution for Treatment‑Resistant Depression
Compass Pathways, a UK pharma pioneer, is advancing psilocybin therapy for treatment‑resistant depression—showing resilience, growth potential, and a bold shift in mental‑health medicine.
3 minutes to read
